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It is well established that individuals with type 1 diabetes (T1D) are at increased risk of other autoimmune 
diseases but the absolute risks are unclear. The aim of this study was to determine the frequency of 
autoantibodies to thyroid peroxidase (TPOA), tissue transglutaminase (TgA), and gastric ATPase 
(ATPase4A) in a well-characterised population based cohort with T1D and to identify the genetic 
characteristics of multiple autoimmunity. 
Samples were analysed from individuals with T1D [n=1061; 464 male; median age 11.8yrs (range 0.7-
28yrs), median age at diagnosis 10.9 yrs (range 0.4-21yrs)] participating in the population-based Bart’s 
Oxford (BOX) family study.  Autoantibodies to TPO, Tg and ATPase were measured by 
radioimmunoassay. HLA class II and non-HLA SNPs (rs3087243 in CTLA-4, rs12935413 in KIAA0350 
and rs1893217 in PTPN2) analysis was carried out by PCR-SSP and Taqman genotyping respectively. 
Overall, 22.7% of individuals with T1D were positive for at least one non-islet autoantibody. The 
prevalence of TPOA, TgA and ATPase4A in patients was 9.2%, 9.1%, and 8.4% respectively. Two 
autoantibodies were observed in 2.8% and all three autoantibodies in 0.3% of the cohort. TgA was 
associated with younger age and TPOA with older age (p<0.001 for both) but no age effect was observed 
for ATPase4A. All autoantibodies were associated with female gender (p<0.005). Risk of multiple 
autoimmunity is modulated by different HLA class II DRB1*03,*04 and non-HLA SNP combinations. 
Over one fifth of children with T1D will develop gut, thyroid or gastric autoimmunity. HLA and non-HLA 
genes modulate risk, supporting evidence for common pathways of autoimmunity. 
  
  
  
